KDU691

  Cat. No.:  DC10746   Featured
Chemical Structure
1513879-19-0
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
KDU691 is a PI4K inhibitor.
Cas No.: 1513879-19-0
Chemical Name: KDU691
Synonyms: KDU691
SMILES: ClC1=CC=C(N(C(C2=CN3C(C=N2)=NC=C3C4=CC=C(C(NC)=O)C=C4)=O)C)C=C1
Formula: C22H18ClN5O2
M.Wt: 419.869
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: KDU691 is a PI4K inhibitor.
In Vivo: During the 5 days of dosing, no major weight changes are observed in the animals that receive KDU691 as prophylactic treatment (group 691-proph). From the fourth day of dosing, the animals that are treated with KDU691 show a transient yellow skin color. The KDU691 radical-cure group (group 691-RC) becomes blood-stage positive again at 31.8±0.5 days p.i. (range, 31 to 32 days). Clinical chemistry analysis of the group 691-RC monkeys reveals that bilirubin levels accumulate during the 5-day radical-cure treatment with KDU691[1].
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC10928 UCB9608 UCB9608 is a Potent, Orally Bioavailable PI4KIIIβ Inhibitor.
DC10540 NVP-BQR695 NVP-BQR695 is a novel PI3K inhibitor.
DC10746 KDU691 KDU691 is a PI4K inhibitor.
X